trending Market Intelligence /marketintelligence/en/news-insights/trending/BCSUfuFw5tXlIsWrxDXsqw2 content esgSubNav
In This List

OJSC Pharmacy Chain 36.6 H1 loss narrows YOY

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Earnings forecasts for US banks; corporate deleveraging; LatAm currency gains


OJSC Pharmacy Chain 36.6 H1 loss narrows YOY

OJSC Pharmacy Chain 36.6 said its normalized net income for the first half came to a loss of 5.19 Russian rubles per share, compared with a loss of 4.59 rubles per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was a loss of 314.3 million rubles, compared with a loss of 479.9 million rubles in the year-earlier period.

Total revenue grew 51.4% on an annual basis to 16.10 billion rubles from 10.64 billion rubles, and total operating expenses grew 40.1% year over year to 15.11 billion rubles from 10.79 billion rubles.

Reported net income totaled 259.0 million rubles, or 4.28 rubles per share, compared to a loss of 397.0 million rubles, or a loss of 3.80 rubles per share, in the prior-year period.

As of Nov. 12, US$1 was equivalent to 65.98 Russian rubles.